Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03176732 · ClinicalTrials.gov registry record
Mechanisms for Individual Differences in Hypertension in Obstructive Sleep
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 155
- Enrollment target
NCT03176732: Completed study, sponsored by University of Pennsylvania.
NCT03176732 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 155 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03176732 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 155 participants
- Enrollment target
Study Summary
Hypertension is a common consequence of obstructive sleep apnea (OSA). However, not all individuals with OSA have hypertension and there are major individual differences in blood pressure response to positive airway pressure treatment of OSA. This project is focused on determining the basis of these individual differences in blood pressure response to OSA and will evaluate the possible underlying reasons for these differences. The results will help clinicians to know whether or not to expect a reduction in blood pressure (BP) to OSA treatment in a given patient and thereby personalize patient management.
Primary Outcome
Measured using 24-hour ambulatory blood pressure monitoring
Interventions
- DEVICE Positive Airway Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2022-06-30 |
What the finished NCT03176732 record still lists
NCT03176732 is an observational study that tracks outcomes without assigning an intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Positive Airway Pressure is the first listed.
NCT03176732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03176732 about?
NCT03176732 is a clinical study titled "Mechanisms for Individual Differences in Hypertension in Obstructive Sleep". Hypertension is a common consequence of obstructive sleep apnea (OSA). However, not all individuals with OSA have hypertension and there are major individual differences in blood pressure response to positive airway pressure treatment of OSA. This project is focused on determining the basis of these...
What is the current status of trial NCT03176732?
This trial is currently completed. The enrollment target is 155 participants. The study started on 2017-06-06. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03176732?
The interventions under investigation include: Positive Airway Pressure (DEVICE).
Who is sponsoring clinical trial NCT03176732?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI